|
 |
| home > epc > winter 2001 > electronic data capture - paving the way for successful clinical trials |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Electronic tools have become more and more important in clinical research over the last few years. As the 'half life' of hardware and telecommunication infrastructure technologies has been shortened during the course of the last decade, extremely quick and reliable electronic data capture (EDC) systems have become available. Today's assortment of Internet- or intranet-based online, offline or hybrid systems allows the implementation of trials with electronic CRFs (e-CRFs) in most countries of the world.
About 15 years ago the pharmaceutical industry started to employ EDC systems in clinical trials. At this time technical infrastructures were unreliable; global networking was still in its infancy; hardware was relatively slow and expensive; and software was hardly programmed with the end user in mind. In addition, the 'landscape' created through EDC was full of pitfalls and uncharted regions not known to the 'olde paper world'. Survival was tough and led to bad experiences for companies - sometimes with lasting effects.
Today, with the help of an 'IT survival kit', a guidebook, and a 'map' of the 'electronic world', these problems can be solved. In a time when online banking and e-commerce are part of everyday life, there are some pharmaceutical companies still in the process of thinking about introducing e-CRFs, while others are implementing new generations of EDC systems based on years of 'hands-on' experience with either home-made or vendor's software.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Biovian expands - and invests in new capacity
More info >> |
|
 |
